Olivier Chosidow, MD, PhD is Chairman of the Department of Dermatology at Hospital Henri Mondor, Créteil, France and co-director of the French satellite of the Cochrane Skin Group. He earned his medical degree in 1987 from Paris 7 University and became board-certified in Dermato-Venereology in 1988. Prof Chosidow early dedicated his career to clinical research, obtaining his master degree from the Department of Clinical Pharmacology in 1988. While serving as an Assistant Professor first in the Department of Dermatology in University Paris 12 and then in the Department of Internal Medicine in University Paris 6, he granted his PhD degree in 1995 and was trained in Clinical Epidemiology in 1997. He became full Professor in 2000 and assumes his current position since 2009. He served both the French Society of Dermatology (Secretary general 2003-2006 and President 2013-to date) and the European Academy of Dermatology (Vice-President of the Paris annual meeting in 2007). His academic and clinical interests are infectious and inflammatory skin diseases, Evidence-based dermatology and Therapeutics, including side-effects of drugs. He has written around 330 scientific publications.
Daniel is a Paediatrician at the Royal Children's Hospital, Melbourne, and Research Fellow at the Centre for International Child Health, University of Melbourne, Australia. He has clinical experience in high scabies prevalence areas in Northern Australia and the Pacific. Current research projects involve complications of group A streptococcal disease, including echocardiographic screening for rheumatic heart disease in Fiji.
Claire is Medical Director of International Foundation for Dermatology and Consultant Dermatologist at Chelsea and Westminster Hospital NHS Foundation Trust, London. As a former Senior Lecturer at the Regional Dermatology Training Centre, Moshi Tanzania she has clinical experience of the practicalities of teaching and practicing in resource poor settings. Her research interests are in dermatological epidemiology in resource poor settings with a particular focus on neglected tropical diseases. In additional to her clinical expertise as a general and paediatric dermatologist for patients of darker skin types, she is also leads a genital dermatoses specialist skin service in the UK.
Roderick James Hay is Chairman of the International Foundation for Dermatology and Professor of Cutaneous Infection and Consultant Dermatologist, Kings College London. He is emeritus Professor of Dermatology, Queens University Belfast (QUB) and honorary professor in the Clinical Research Unit, London School of Hygiene and Tropical Medicine. He was previously Head of the School of Medicine and Dentistry and Dean of the Faculty of Medicine and Health Sciences, QUB. Before this he was Dean and Clinical Director of the St John’s Institute of Dermatology, London. He studied in Oxford University and Guys Hospital Medical School and after training in London and at the Centres for Disease Control, Atlanta; his first consultant post was in St John Hospital for Diseases of the Skin. He was appointed to the Mary Dunhill Chair of Cutaneous Medicine in London University in 1989. His academic and clinical interests are infectious skin disease, mycoses and tropical public health. He is former President of the British Association of Dermatologists and is a Fellow of the Academy of Medical Sciences.
Pat Lammie is Principal Investigator on the 'Filling the Gaps' grant to the Neglected Tropical Diseases Support Center at the Task Force for Global Health, where he provides technical guidance and strategic oversight to the projects. Pat is also a Senior Staff Scientist in the Disease Elimination and Control Group in the Division of Parasitic Diseases and Malaria at the Centers for Disease Control and Prevention (CDC). Pat received his PhD from Tulane University in 1983 following doctoral research on the immunology of experimental filariasis. He has been at CDC for more than 20 years where his principal focus has been lymphatic filariasis. His laboratory is heavily invested in efforts to develop new tools and strategies to monitor and evaluate filariasis and other NTDs.
Diana Martin is a Microbiologist at the Centers for Disease Control and Prevention in Atlanta, GA, USA. Diana has only recently begun studying scabies as part of a study examining the impact of mass drug administration programs for lymphatic filariasis and trachoma on non-targeted diseases. Diana’s background is in immunoparasitology, with a primary focus on T cell responses to Trypanosoma cruzi infection and their relationship to disease pathogenesis. Current areas of research are development of serological tests to monitor trachoma MDA programs, the general health impact of NTD programs, and potential transmission of Chagas disease via tissue transplantation.
James McCarthy leads a multidisciplinary research team at the Queensland Institute of Medical Research undertaking research in human parasitology and translational research in tropical medicine. He holds a senior leadership position at QIMR, as Head of the Programme of Infectious Diseases, and serves as the QIMR representative in the Australian Infectious Diseases Research Centre. He is a Senior Consultant Physician in Infectious Diseases at the Royal Brisbane and Womens Hospital, and a Conjoint Professor of Medicine at The University of Queensland. His research areas include using experimental human malaria infection to improve the understanding of the pathogenesis of malaria and to develop new diagnostics, drugs and vaccines, improving the diagnosis and treatment of scabies and intestinal helminth infections and clinical trials of new drugs and vaccines for infectious diseases.
Andrew Steer is a Consultant Paediatrician and Infectious Diseases Physician at the Royal Children’s Hospital in Melbourne, and also holds positions as a Senior Research Fellow at the Centre for International Child Health in the University of Melbourne, and as an Honorary Research Fellow at the Murdoch Children’s Research Institute and the Menzies School of Health Research, Australia. Andrew has worked on scabies epidemiology in the Pacific since 1997 and is currently leading a mass drug administration trial of ivermectin and permethrin versus standard care in Fiji. Andrew's other research interests are group A streptococcal clinical and molecular epidemiology; group A streptococcal vaccine research; rheumatic heart disease pathogenesis, epidemiology and control; and epidemiology and control of tropical childhood bacterial skin diseases.
In addition to the Steering Committee, the following people have key roles in IACS activities:
Margot Whitfeld Lead, Advocacy and Fundraising
David Hendrickx Lead, Control Scabies Online
Katja Fischer Co-lead, Research and Publications
Kate Mounsey Co-lead, Research and Publications
Contact us at email@example.com